Zobrazeno 1 - 10
of 273
pro vyhledávání: '"H, Magdelénat"'
Autor:
J. Rouessé, H. Magdelénat
Publikováno v:
Oncologie. 21:01-02
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae4404719376ff172b090a93a2b1ff0e
https://doi.org/10.3166/onco-2019-0022
https://doi.org/10.3166/onco-2019-0022
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 7:37-40
Resume L'anticorps M85 utilise dans le dosage immunofluorimetrique par competition «BCM-IMx (Abbott) reconnait un determinant antigenique carbohydrate caracteristique des chaines lactosamines de type 2 et des «crypto-antigenes, ce qui le distingue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2db1be3cebd75bb1e6ec00e872ee238a
https://doi.org/10.1016/s0923-2532(05)80150-4
https://doi.org/10.1016/s0923-2532(05)80150-4
Autor:
H. Magdelénat
Publikováno v:
ONCOLOGIE. 6
Grâce aux microprelevements et aux micro–analyses, les traitements neo–adjuvants permettent d’analyser les caracteristiques biologiques tumorales en relation avec les reponses cliniques et histologiques dont on a, par des essais therapeutiques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac2ffb4e811dabaf63c8593ce17e6f5
https://doi.org/10.1007/s10269-004-0032-9
https://doi.org/10.1007/s10269-004-0032-9
Autor:
B, Zafrani, M H, Aubriot, E, Mouret, P, De Crémoux, Y, De Rycke, A, Nicolas, E, Boudou, A, Vincent-Salomon, H, Magdelénat, X, Sastre-Garau
Publikováno v:
Histopathology. 37(6)
The hormone receptor (HR) status of breast cancer is an important prognostic factor and predictive parameter of the response to hormone therapy. Enzyme immunoassay (EIA) is currently the standard for determination of HR, but immunohistochemistry (IHC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::838672aff4c62b78d14a3d4937e0ce85
https://pubmed.ncbi.nlm.nih.gov/11260308
https://pubmed.ncbi.nlm.nih.gov/11260308
Autor:
P, de Cremoux, J M, Extra, M G, Denis, J Y, Pierga, E, Bourstyn, C, Nos, K B, Clough, E, Boudou, E C, Martin, A, Müller, P, Pouillart, H, Magdelénat
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(8)
We have prospectively analyzed blood samples of 122 patients with breast disease for the presence of circulating expressing MUC1 cells before and after treatment. Among them, 28 patients had histologically confirmed benign breast disease (group 1), 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f75db1a439ce81a0414280968d69ca17
https://pubmed.ncbi.nlm.nih.gov/10955792
https://pubmed.ncbi.nlm.nih.gov/10955792
Autor:
P, Masdehors, S, Omura, H, Merle-Béral, F, Mentz, J M, Cosset, J, Dumont, H, Magdelénat, J, Delic
Publikováno v:
British journal of haematology. 105(3)
Ubiquitin-proteasome-dependent protein processing appears to be an essential component in the control of radiation-induced apoptosis in human lymphocytes. This control is altered in chronic lymphocytic leukaemia (CLL), compared to that of normal huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1087a830e8fa28e8f9a487dc5f951517
https://pubmed.ncbi.nlm.nih.gov/10354141
https://pubmed.ncbi.nlm.nih.gov/10354141
Publikováno v:
Breast cancer research and treatment. 49(3)
The expression of estrogen (ER) and progesterone (PgR) receptors was analyzed in a retrospective series of 3000 patients who had operable primary breast cancer. Patients were stratified according to ER and PgR status and the study was focused on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25aa9cc54e45b3220ede7a8f05e8e5a1
https://pubmed.ncbi.nlm.nih.gov/9776505
https://pubmed.ncbi.nlm.nih.gov/9776505
Publikováno v:
Breast cancer research and treatment. 41(2)
All French laboratories that routinely assay estradiol (ER) and progesterone (PR) receptors participate in the European EORTC quality control program based on twice-yearly analysis of 5 cytosolic preparations. This system has considerably reduced int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e50948be5adc281c0eddbf200209bfe4
https://pubmed.ncbi.nlm.nih.gov/8944331
https://pubmed.ncbi.nlm.nih.gov/8944331
Autor:
S, Romain, F, Spyratos, C, Lainé-Bidron, C, Bouchet, O, Guirou, P M, Martin, J, Oglobine, H, Magdelénat
Publikováno v:
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies. 33(9)
The urokinase type plasminogen activator (u-PA) and the plasminogen activator inhibitor-1 (PAI-1) are among the best second-generation prognostic tissue factors in breast cancer. However, different extraction procedures and assay kits are used in dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::199870434a3fa46a34b466e162d916b8
https://pubmed.ncbi.nlm.nih.gov/8611670
https://pubmed.ncbi.nlm.nih.gov/8611670
Publikováno v:
Bulletin du cancer. 81(12)
The development of biotechnologies offers considerable potential for new therapeutical approaches, targetting nucleic acids as information bearing molecules responsible for various pathologies. Gene therapy has, up to now, mainly aimed at compensatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a4a66e322da07af8c36cdc62a5a0945
https://pubmed.ncbi.nlm.nih.gov/7742591
https://pubmed.ncbi.nlm.nih.gov/7742591